Jean-Jacques Kiladjian

Jean-Jacques Kiladjian

UNVERIFIED PROFILE

Are you Jean-Jacques Kiladjian?   Register this Author

Register author
Jean-Jacques Kiladjian

Jean-Jacques Kiladjian

Publications by authors named "Jean-Jacques Kiladjian"

Are you Jean-Jacques Kiladjian?   Register this Author

100Publications

3275Reads

46Profile Views

How much does 2016 WHO classification of myeloproliferative neoplasms affect the clinic?

Expert Rev Hematol 2019 Jul 4;12(7):473-476. Epub 2019 Jun 4.

b Inserm UMRS-1131, IUH, Hopital Saint-Louis , Paris , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2019.1623019DOI Listing
July 2019

Thromboembolic events in polycythemia vera.

Ann Hematol 2019 May 8;98(5):1071-1082. Epub 2019 Mar 8.

Hospital del Mar-IMIM, Passeig Marítim 25-29, 08003, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-019-03625-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469649PMC
May 2019

Luspatercept for the treatment of anemia in myelodysplastic syndromes and primary myelofibrosis.

Blood 2019 02 2;133(8):790-794. Epub 2019 Jan 2.

Medical Clinic and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-11-876888DOI Listing
February 2019

Next-generation sequencing for JAK2 mutation testing: advantages and pitfalls.

Ann Hematol 2019 Jan 26;98(1):111-118. Epub 2018 Sep 26.

APHP, Laboratoire de Biologie Cellulaire, Hopital Saint-Louis, 1 avenue Claude Vellefaux, 75010, Paris, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00277-018-3499-y
Publisher Site
http://dx.doi.org/10.1007/s00277-018-3499-yDOI Listing
January 2019

Endothelial Cells Harbouring the JAK2V617F Mutation Display Pro-Adherent and Pro-Thrombotic Features.

Thromb Haemost 2018 Sep 13;118(9):1586-1599. Epub 2018 Aug 13.

INSERM, UMRS_1131, Institut Universitaire d'Hématologie, Université Paris-Diderot, Hopital Saint-Louis, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1667015DOI Listing
September 2018

Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features.

J Clin Oncol 2018 Aug 28:JCO2018788414. Epub 2018 Aug 28.

Anna L. Godfrey, Jacob Grinfeld, and Anthony R. Green, Cambridge University Hospitals National Health Service (NHS) Foundation Trust; Peter J. Campbell and Jyoti Nangalia, Wellcome Trust Sanger Institute, Hinxton; Cathy MacLean, Julia Cook, Julie Temple, and Anthony R. Green, University of Cambridge; Anthony R. Green, Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge; Georgina Buck, University of Oxford, Oxford; Bridget S. Wilkins and Claire N. Harrison, Guy's and St Thomas' NHS Foundation Trust, London; Keith Wheatley, University of Birmingham, Birmingham; Mary Frances McMullin, Queen's University Belfast, Belfast, United Kingdom; Cecily Forsyth, Gosford Hospital, Gosford, and Australasian Leukaemia and Lymphoma Group, Australia; and Jean-Jacques Kiladjian, Hôpital Saint-Louis, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.8414DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269131PMC
August 2018

SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis.

J Clin Oncol 2017 Dec 20;35(34):3844-3850. Epub 2017 Sep 20.

Ruben A. Mesa, Mayo Clinic Cancer Center, Scottsdale, AZ; Jean-Jacques Kiladjian, Saint-Louis Hospital (Assistance Publique-Hôpitaux de Paris) and Paris Diderot University, Paris, France; John V. Catalano, Frankston Hospital and Monash University, Melbourne, Victoria, Australia; Timothy Devos, University Hospital Leuven and Katholieke Universiteit Leuven, Leuven, Belgium; Miklos Egyed, Kaposi Mor Teaching Hospital, Kaposvar, Hungary; Andrzei Hellmann, Medical University of Gdańsk, Gdańsk, Poland; Donal McLornan, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Kazuya Shimoda, University of Miyazaki, Miyazaki, Japan; Elliott F. Winton, Emory University School of Medicine, Atlanta, GA; Wei Deng, Ronald L. Dubowy, and Julia D. Maltzman, Gilead Sciences, Foster City; Jason Gotlib, Stanford Cancer Institute, Stanford, CA; and Francisco Cervantes, Hospital Clinic, Institut D'Investigacions Biomèdiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.73.4418
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.73.4418DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553796PMC
December 2017

Clonal Hematopoiesis and Atherosclerosis.

N Engl J Med 2017 10;377(14):1400-1

Hôpital Saint-Louis, Paris, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1710381DOI Listing
October 2017

Selective testing for calreticulin gene mutations in patients with splanchnic vein thrombosis: A prospective cohort study.

J Hepatol 2017 09 5;67(3):501-507. Epub 2017 May 5.

UPMC, Univ Paris 06, GRC n°7, Groupe de Recherche Clinique sur les Myéloproliférations Aiguës et Chroniques MYPAC, Paris, France; Laboratoire d'Immunologie et Hématologie Biologique, Hôpital Saint-Antoine, AP-HP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.04.021DOI Listing
September 2017

Enhanced calreticulin expression in red cells of polycythemia vera patients harboring the mutation.

Haematologica 2017 07 6;102(7):e241-e244. Epub 2017 Apr 6.

Université Sorbonne Paris Cité, Université Paris Diderot, INSERM, INTS, Unité Biologie Intégrée du Globule Rouge, Laboratoire d'Excellence GR-Ex, Paris, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2016.161604DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566046PMC
July 2017

Markers of iron deficiency in patients with polycythemia vera receiving ruxolitinib or best available therapy.

Leuk Res 2017 05 31;56:52-59. Epub 2017 Jan 31.

CRIMM-Center of Research and Innovation for Myeloproliferative Neoplasms, AOU Careggi and University of Florence, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2017.01.032DOI Listing
May 2017

Long-term treatment with interferon alfa for myeloproliferative neoplasms.

Lancet Haematol 2017 04 11;4(4):e150-e151. Epub 2017 Mar 11.

Assistance Publique-Hopitaux de Paris, Hopital Saint-Louis, Université Paris Diderot, INSERM CIC 1427, Paris, France; Centre d'Investigations Cliniques, Hopital Saint-Louis, Paris 75010, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23523026173003
Publisher Site
http://dx.doi.org/10.1016/S2352-3026(17)30039-XDOI Listing
April 2017

Chemotherapy for post-myelofibrosis acute myeloid leukemia: eradication of the leukemic clone but not the MPN clone.

Leuk Lymphoma 2017 03 11;58(3):749-751. Epub 2016 Aug 11.

e Centre d'Investigations Cliniques , Hopital Saint-Louis , Paris , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1213833DOI Listing
March 2017

[Not Available].

Bull Cancer 2016 Jun;103(6 Suppl 1):S29-38

Centre d'Investigations Cliniques, Hôpital Saint-Louis, APHP, Paris, France.; Inserm UMR-S 1131, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0007-4551(16)30143-6DOI Listing
June 2016

Ruxolitinib: a targeted treatment option for patients with polycythemia vera.

Blood Lymphat Cancer 2016 12;6:7-19. Epub 2016 May 12.

Clinical Investigations Center, Hôpital Saint-Louis et Université Paris Diderot, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/BLCTT.S101185DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467337PMC
May 2016

Current therapies and their indications for the Philadelphia-negative myeloproliferative neoplasms.

Am Soc Clin Oncol Educ Book 2015 :e389-96

From the Clinical Investigations Center, Hôpital Saint-Louis, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2015.35.e389DOI Listing
February 2016

Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease.

J Clin Oncol 2016 Jan 23;34(2):151-9. Epub 2015 Nov 23.

Holly Geyer, Robyn Scherber, Heidi Kosiorek, Amylou C. Dueck, and Ruben A. Mesa, Mayo Clinic, Scottsdale, AZ; Jean-Jacques Kiladjian, Hospital Saint-Louis, Paris; Francoise Boyer, Centre Hospitalier Universitaire, Angers; Gabriel Etienne, Institut Bergonie, Bordeaux; Jean-Christophe Ianotto, Centre Hospitalier Universitaire, Brest; Dana Ranta, Centre Hospitalier Universitaire, Grenoble; Lydia Roy, Centre Hospitalier Universitaire, Poitiers; Jean-Yves Cahn, Centre Hospitalier Universitaire, Grenoble, France; Zhijian Xiao, Zefeng Xu, Yue Zhang, Xiujuan Sun, Junqing Xu, and Peihong Zhang, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China; Stefanie Slot and Sonja Zweegman, VU University Medical Center, Amsterdam; Peter A.W. te Boekhorst, Erasmus Medical Center, Rotterdam; Suzan Commandeur, Leiden University Medical Center, Leiden; Harry Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Frederico Sackmann, Fundaleu, Buenos Aires, Argentina; Ana Kerguelen Fuentes and Dolores Hernández-Maraver, University Hospital La Paz, Madrid; Carlos Besses, Hospital del Mar; Francisco Cervantes, University of Barcelona, Barcelona, Spain; Konstanze Döhner and Frank Stegelmann, University Hospital of Ulm; Karin Bonatz and Andreas Reiter, Universitätsmedizin Mannheim, Mannheim; Heike L. Pahl, University Hospital Freiburg, Freiburg; Martin Griesshammer, Johannes Wesling Klinikum Minden, Germany; Claire N. Harrison and Deepti Radia, Guy's and St Thomas NHS Foundation Trust; Robert Peter Gale, Imperial College, London, United Kingdom; Pablo Muxi, Hospital Británico, Montevideo, Uruguay; Peter L. Johansson and Bjorn Andreasson, NU Hospital Organization, Uddevalla; Gunnar Birgegard, University Hospital, Uppsala; Jan Samuelsson, Stockholm South Hospital, Stockholm, Sweden; Alessandro Rambaldi, Tiziano Barbui, and Maria L. Ferrari, Ospedali Riuniti di Bergamo, Bergamo; Giovanni Barosi, IRCCS Policlinico S. Matteo Foundation; Franc

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.9337DOI Listing
January 2016

Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations.

Blood 2015 Dec 20;126(24):2585-91. Epub 2015 Oct 20.

Université Paris Diderot, Paris, France; and Centre d'Investigations Cliniques, Hopital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-07-659060DOI Listing
December 2015

Myeloproliferative neoplasms and personalized medicine: the perfect match?

Haematologica 2015 Dec;100(12):1493-4

Guy's and St Thomas' NHS Foundation Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2015.137182DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666324PMC
December 2015

Ruxolitinib for the treatment of patients with polycythemia vera.

Expert Rev Hematol 2015 Aug 17;8(4):391-401. Epub 2015 May 17.

Hôpital Saint-Louis and Université Paris Diderot, Paris, France.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/17474086.2015.10
Publisher Site
http://dx.doi.org/10.1586/17474086.2015.1045869DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627585PMC
August 2015

Ruxolitinib versus standard therapy for the treatment of polycythemia vera.

N Engl J Med 2015 Jan;372(5):426-35

From Azienda Ospedaliera-Universitaria Careggi, University of Florence, Florence (A.M.V.), Ospedale di Circolo e Fondazione Macchi, Varese (F. Passamonti), and University of Naples Federico II, Naples (F. Pane) - all in Italy; Hôpital Saint-Louis et Université Paris Diderot, Paris (J.J.K.); Johannes Wesling Clinic, Minden, Germany (M.G.); St. István and St. László Hospital and Semmelweis University, Budapest, Hungary (T.M.); Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia (S.D.); Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.); Ziekenhuis Netwerk Antwerpen Stuivenberg, Antwerp, Belgium (P.Z.); Mayo Clinic Cancer Center, Scottsdale, AZ (R.M.); Incyte, Wilmington, DE (S.H., M.M.J., W.G.); Novartis Pharmaceuticals, East Hanover, NJ (J.L., D.H.); Novartis Pharma, Basel, Switzerland (U.P.); and University of Texas M.D. Anderson Cancer Center, Houston (S.V.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1409002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358820PMC
January 2015

Interferon alfa therapy in CALR-mutated essential thrombocythemia.

N Engl J Med 2014 Jul;371(2):188-9

Hôpital Saint-Louis, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1401255DOI Listing
July 2014

TET2 gene sequencing may be helpful for myeloproliferative neoplasm diagnosis.

Br J Haematol 2014 May 16;165(3):416-9. Epub 2014 Jan 16.

AP-HP, Service de Biologie Cellulaire, Hopital Saint-Louis, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12738DOI Listing
May 2014

The spectrum of JAK2-positive myeloproliferative neoplasms.

Hematology Am Soc Hematol Educ Program 2012 ;2012:561-6

Saint-Louis Hospital and Paris Diderot University, Paris, France.

View Article

Download full-text PDF

Source
http://asheducationbook.hematologylibrary.org/content/2012/1
Web Search
http://dx.doi.org/10.1182/asheducation-2012.1.561DOI Listing
June 2013

Is there a role for the use of IFN-α in primary myelofibrosis?

Hematology Am Soc Hematol Educ Program 2012 ;2012:567-70

Stanford University School of Medicine, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2012.1.567DOI Listing
June 2013

Treatment target in polycythemia vera.

N Engl J Med 2013 04;368(16):1554-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1301262DOI Listing
April 2013

Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis.

Expert Rev Hematol 2013 Feb;6(1):49-58

Myeloproliferative Disease Center, Division of Hematology-Oncology, Weill Cornell Medical Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/ehm.12.69DOI Listing
February 2013

Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis.

Blood 2012 Dec 4;120(25):4921-8. Epub 2012 Oct 4.

Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2011-09-37
Publisher Site
http://dx.doi.org/10.1182/blood-2011-09-376517DOI Listing
December 2012

Live and let (MPN cells) die!

Blood 2012 Oct;120(15):2933-4

Hôpital Saint-Louis.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2012-08-45
Publisher Site
http://dx.doi.org/10.1182/blood-2012-08-450056DOI Listing
October 2012

Treatment of polycythemia vera with hydroxyurea and pipobroman: final results of a randomized trial initiated in 1980.

J Clin Oncol 2011 Oct 12;29(29):3907-13. Epub 2011 Sep 12.

Hôpital Saint-Louis, AP-HP, 1 avenue Claude Vellefaux, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.36.0792DOI Listing
October 2011

Identification of JAK2 mutations in canine primary polycythemia.

Exp Hematol 2011 May 12;39(5):542-5. Epub 2011 Feb 12.

Unité INSERM UMR-S 940, Hôpital Saint-Louis, 1 Avenue Claude Vellefaux, Paris, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0301472X110006
Publisher Site
http://dx.doi.org/10.1016/j.exphem.2011.02.003DOI Listing
May 2011

The renaissance of interferon therapy for the treatment of myeloid malignancies.

Blood 2011 May 9;117(18):4706-15. Epub 2011 Mar 9.

Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-08-258772DOI Listing
May 2011

Interferon-alpha in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms. Status and perspectives.

Curr Drug Targets 2011 Mar;12(3):392-419

Department of Hematology, Copenhagen University Hospital, Roskilde Hospital, Roskilde, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/138945011794815275DOI Listing
March 2011